SHELBY MIHALIC: Open Payments
NPI 1043980089 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$800 in 38 payments from 15 companies in 2025. Trend: 2023 $264 · 2024 $446 · 2025 $800
Food & beverage: $800
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 16 | $224 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $180 |
| CSL Behring | 2 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| Genentech USA, Inc. | 1 | $32 |
| Greer Laboratories, Inc. | 1 | $29 |
| Pharming Healthcare, Inc. | 1 | $28 |
| Amgen Inc. | 1 | $28 |
Products named: DUPIXENT, NEFFY, Andembry, TEZSPIRE, Xolair, ORALAIR, RUCONEST, OPZELURA.
Industry payments across SC — which companies pay providers there.
